At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Nov 9, 2026 at 16:29 ET
Two Edwards Lifesciences insiders, including the CEO, executed open-market sales totaling approximately $5.99M on November 9, 2026, following the company's Q3 earnings beat and raised guidance reported on November 4. Both sales were conducted under 10b5-1 trading plans, and the CEO's sale was part of a same-day exercise-and-sell transaction. The total value represents about 0.01% of the company's $57.9B market cap, making the cluster economically trivial.
- CEO Bernard Zovighian sold 23,100 shares in two open-market trades totaling $2.38M on Nov 9, 2026
- CVP Donald Bobo Jr. sold 48,900 shares for $5.04M on Nov 9, 2026
- Both sales were executed under 10b5-1 trading plans
- The CEO's sale was part of a same-day derivative exercise (23,100 options exercised at $72.68)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access